NasdaqCM - Delayed Quote • USD
The Oncology Institute, Inc. (TOI)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 4:08 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.12 | -0.09 | -0.36 | -0.17 |
| Low Estimate | -0.12 | -0.09 | -0.36 | -0.17 |
| High Estimate | -0.12 | -0.09 | -0.36 | -0.17 |
| Year Ago EPS | -0.25 | -0.19 | -0.92 | -0.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 95.16M | 102.46M | 412.5M | 482.8M |
| Low Estimate | 95.16M | 102.46M | 412.5M | 482.8M |
| High Estimate | 95.16M | 102.46M | 412.5M | 482.8M |
| Year Ago Sales | 76.19M | 80.22M | 324.24M | 412.5M |
| Sales Growth (year/est) | 24.90% | 27.70% | 27.20% | 17.00% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.18 | -0.17 | -0.13 | -0.11 |
| EPS Actual | -0.25 | -0.19 | -0.19 | -0.21 |
| Difference | -0.07 | -0.02 | -0.06 | -0.1 |
| Surprise % | -38.90% | -11.80% | -46.20% | -90.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.09 | -0.36 | -0.17 |
| 7 Days Ago | -0.12 | -0.09 | -0.36 | -0.17 |
| 30 Days Ago | 0 | 0 | -0.39 | -0.19 |
| 60 Days Ago | 0 | 0 | -0.41 | -0.22 |
| 90 Days Ago | 0 | 0 | -0.41 | -0.22 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TOI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 52.00% | -- | -- | 0.80% |
| Next Qtr. | 52.60% | -- | -- | 9.60% |
| Current Year | 60.90% | -- | -- | 4.50% |
| Next Year | 52.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Guggenheim: Buy | 6/16/2023 |
| Maintains | Guggenheim: Neutral | 3/20/2023 |
| Maintains | Guggenheim: Buy | 11/11/2022 |
| Initiated | Jefferies: Buy | 8/15/2022 |
Related Tickers
MODV ModivCare Inc.
20.13
-3.03%
GBNHF Greenbrook TMS Inc.
0.0950
+16.56%
PIII P3 Health Partners Inc.
0.5010
+0.18%
AONC American Oncology Network, Inc.
4.5200
-16.30%
PNTG The Pennant Group, Inc.
19.89
-0.60%
EHAB Enhabit, Inc.
10.11
-0.49%
INNV InnovAge Holding Corp.
4.0000
0.00%
ASTH Astrana Health, Inc.
37.09
-0.86%
JYNT The Joint Corp.
11.92
-0.83%
4004.SR Dallah Healthcare Company
169.80
+1.07%